Literature DB >> 23558015

Correlates of T-cell-mediated viral control and phenotype of CD8(+) T cells in HIV-2, a naturally contained human retroviral infection.

Thushan I de Silva1, Yanchun Peng, Aleksandra Leligdowicz, Irfan Zaidi, Lucy Li, Harry Griffin, Marie-Eve Blais, Tim Vincent, Mavinga Saraiva, Louis-Marie Yindom, Carla van Tienen, Philippa Easterbrook, Assan Jaye, Hilton Whittle, Tao Dong, Sarah L Rowland-Jones.   

Abstract

While a significant proportion of HIV-2-infected individuals are asymptomatic and maintain undetectable viral loads (controllers), 15% to 20% progress to AIDS and are predicted by detectable viremia. Identifying immune correlates that distinguish these 2 groups should provide insights into how a potentially pathogenic retrovirus can be naturally controlled. We performed a detailed study of HIV-2-specific cellular responses in a unique community cohort in Guinea-Bissau followed for over 2 decades. T-cell responses were compared between controllers (n = 33) and viremic subjects (n = 27) using overlapping peptides, major histocompatibility complex class I tetramers, and multiparameter flow cytometry. HIV-2 viral control was significantly associated with a high-magnitude, polyfunctional Gag-specific CD8(+) T-cell response but not with greater perforin upregulation. This potentially protective HIV-2-specific response is surprisingly narrow. HIV-2 Gag-specific CD8(+) T cells are at an earlier stage of differentiation than cytomegalovirus-specific CD8(+) T-cells, do not contain high levels of cytolytic markers, and exhibit low levels of activation and proliferation, representing distinct properties from CD8(+) T cells associated with HIV-1 control. These data reveal the potential T-cell correlates of HIV-2 control and the detailed phenotype of virus-specific CD8(+) T cells in a naturally contained retroviral infection.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23558015     DOI: 10.1182/blood-2012-12-472787

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  22 in total

1.  HIV-1 and HIV-2 differentially mature plasmacytoid dendritic cells into IFN-producing cells or APCs.

Authors:  Caroline M Royle; David R Graham; Simone Sharma; Dietmar Fuchs; Adriano Boasso
Journal:  J Immunol       Date:  2014-08-25       Impact factor: 5.422

2.  Differential impact of magnitude, polyfunctional capacity, and specificity of HIV-specific CD8+ T cell responses on HIV set point.

Authors:  Catherine Riou; Wendy A Burgers; Koleka Mlisana; Richard A Koup; Mario Roederer; Salim S Abdool Karim; Carolyn Williamson; Clive M Gray
Journal:  J Virol       Date:  2013-11-13       Impact factor: 5.103

3.  Human immunodeficiency virus type 2 infections in Austria.

Authors:  Ninon Taylor; Jan Marco Kern; Wolfgang Prammer; Alois Lang; Bernhard Haas; Martin Gisinger; Robert Zangerle; Alexander Egle; Richard Greil; Hannes Oberkofler; Josef Eberle
Journal:  Wien Klin Wochenschr       Date:  2014-01-18       Impact factor: 1.704

4.  Polyfunctional T-Cell Signatures to Predict Protection from Cytomegalovirus after Lung Transplantation.

Authors:  Laurie D Snyder; Cliburn Chan; Darongsae Kwon; John S Yi; Jessica A Martissa; C Ashley Finlen Copeland; Robyn J Osborne; Sara D Sparks; Scott M Palmer; Kent J Weinhold
Journal:  Am J Respir Crit Care Med       Date:  2016-01-01       Impact factor: 21.405

5.  HIV-2 infection is associated with preserved GALT homeostasis and epithelial integrity despite ongoing mucosal viral replication.

Authors:  S M Fernandes; A R Pires; P Matoso; C Ferreira; H Nunes-Cabaço; L Correia; E Valadas; J Poças; P Pacheco; H Veiga-Fernandes; R B Foxall; A E Sousa
Journal:  Mucosal Immunol       Date:  2017-05-17       Impact factor: 7.313

Review 6.  Engineering broadly neutralizing antibodies for HIV prevention and therapy.

Authors:  Casey K Hua; Margaret E Ackerman
Journal:  Adv Drug Deliv Rev       Date:  2016-01-29       Impact factor: 15.470

Review 7.  Delayed disease progression in HIV-2: the importance of TRIM5α and the retroviral capsid.

Authors:  M T Boswell; S L Rowland-Jones
Journal:  Clin Exp Immunol       Date:  2019-03-21       Impact factor: 4.330

Review 8.  Isotype Diversification of IgG Antibodies to HIV Gag Proteins as a Therapeutic Vaccination Strategy for HIV Infection.

Authors:  Martyn A French; Laila N Abudulai; Sonia Fernandez
Journal:  Vaccines (Basel)       Date:  2013-08-09

9.  Protection versus pathology in aviremic and high viral load HIV-2 infection-the pivotal role of immune activation and T-cell kinetics.

Authors:  Andrea Hegedus; Samuel Nyamweya; Yan Zhang; Sheila Govind; Richard Aspinall; Alla Mashanova; Vincent A A Jansen; Hilton Whittle; Assan Jaye; Katie L Flanagan; Derek C Macallan
Journal:  J Infect Dis       Date:  2014-05-05       Impact factor: 5.226

10.  Early skewed distribution of total and HIV-specific CD8+ T-cell memory phenotypes during primary HIV infection is related to reduced antiviral activity and faster disease progression.

Authors:  Yanina Ghiglione; Juliana Falivene; María Julia Ruiz; Natalia Laufer; María Eugenia Socías; Pedro Cahn; Luis Giavedoni; Omar Sued; María Magdalena Gherardi; Horacio Salomón; Gabriela Turk
Journal:  PLoS One       Date:  2014-08-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.